The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy
Lung cancer is well known for its high mortality worldwide. The treatment for advanced lung cancer needs more attention to improve its survival time. A disintegrin and metallopeptidase with thrombospondin motifs 8 (ADAMTS8) has been linked to several cancer types. However, its role in lung cancer is...
Main Authors: | Hsiao-Chen Lee, Chao-Yuan Chang, Kuan-Li Wu, Hung-Hsing Chiang, Yung-Yun Chang, Lian-Xiu Liu, Yung-Chi Huang, Jen-Yu Hung, Ya-Ling Hsu, Yu-Yuan Wu, Ying-Ming Tsai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/6/902 |
Similar Items
-
Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma
by: Hsiao-Chen Lee, et al.
Published: (2022-05-01) -
Serum Level of ADAMTS4 and ADAMTS8 in Patients with Psoriatic Arthritis
by: Irmak Icen Taskin, et al.
Published: (2020-12-01) -
Bioinformatics Analysis and Functional Verification of ADAMTS9-AS1/AS2 in Lung Adenocarcinoma
by: Wei Liu, et al.
Published: (2021-07-01) -
ADAMTS8 inhibits glioma development in vitro and in vivo
by: Baosheng Zhou, et al.
Published: (2023-07-01) -
Matrilin-2 Is Proteolytically Cleaved by ADAMTS-4 and ADAMTS-5
by: Zhengke Wang, et al.
Published: (2014-06-01)